SLC5A2 and asthma: Asthma: We identified an indirect effect of SGLT2 inhibition on asthma through the Degree of unsaturation (Fatty Acids) (OR: 0.762, 95% CI: 0.692–0.839, P = 2.75×10-8), Ratio of docosahexaenoic acid to total fatty acids (OR: 0.809, 95% CI: 0.734–0.891, P = 1.69×10-5),4-androsten-3beta,17beta-diol disulfate 2*(OR: 0.663, 95% CI: 0.540–0.814, P = 8.60×10-5),with a mediated proportion of 8.10% (95% CI: 0.042–0.119, P = 0.036), 6.96% (95% CI: 0.039–0.101, P = 0.025), 32.71% (95% CI: 0.181–0.473, P = 0.025), of the total effect.